Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Determining which budgeting method is best can transform your financial health. Explore various approaches and find your ideal fit.
21,883 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Investors are rethinking AI bets as Bank of America flags doubts around revolution emerging. The new caution hints at...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
Ray Dalio wraps a 10-day China-focused Asia tour, warning that a realignment of global power could reshape markets an...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
Home Depot is rebuilding retailing with a bold AI-driven strategy, refreshing its technology leadership and rolling o...
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...
A market strategist argues the AI urge to spend is cooling, transferring momentum from software giants to chipmakers ...
Honeywell slashed the price of a $1.92 billion chemicals acquisition by $500 million, a 26% concession tied to softer...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
The S&P 500’s top ten names now control a record share of the index, a dynamic that could ripple into Bitcoin and the...